62 related articles for article (PubMed ID: 25510806)
1. Improving outcomes in advanced DLBCL: systemic approaches and radiotherapy.
Boyle J; Beaven AW; Diehl LF; Prosnitz LR; Kelsey CR
Oncology (Williston Park); 2014 Dec; 28(12):1074-81, 1084. PubMed ID: 25510806
[TBL] [Abstract][Full Text] [Related]
2. Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis.
Berger MD; Trelle S; Büchi AE; Jegerlehner S; Ionescu C; Lamy de la Chapelle T; Novak U
Haematologica; 2021 Jul; 106(7):1923-1931. PubMed ID: 32554560
[TBL] [Abstract][Full Text] [Related]
3. Dramatic radiotherapy response in a necrotic lymphoma mass: a case report.
McNeil N; Gorayski P; Blunt D; Roos D
J Med Case Rep; 2020 Jul; 14(1):118. PubMed ID: 32718327
[TBL] [Abstract][Full Text] [Related]
4. New therapies in non-Hodgkin lymphoma.
Novelli S; Sierra J; Briones J
Expert Rev Anticancer Ther; 2015 Mar; 15(3):349-59. PubMed ID: 25582186
[TBL] [Abstract][Full Text] [Related]
5. Genetic lesions in diffuse large B-cell lymphomas.
Testoni M; Zucca E; Young KH; Bertoni F
Ann Oncol; 2015 Jun; 26(6):1069-1080. PubMed ID: 25605746
[TBL] [Abstract][Full Text] [Related]
6. Primary mediastinal lymphoma: diagnosis and treatment options.
Martelli M; Di Rocco A; Russo E; Perrone S; Foà R
Expert Rev Hematol; 2015 Apr; 8(2):173-86. PubMed ID: 25537750
[TBL] [Abstract][Full Text] [Related]
7. Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab.
Berinstein NL; Bhella S; Pennell NM; Cheung MC; Imrie KR; Spaner DE; Milliken V; Zhang L; Hewitt K; Boudreau A; Reis MD; Chesney A; Good D; Ghorab Z; Hicks LK; Piliotis E; Buckstein R
Ann Hematol; 2015 May; 94(5):813-23. PubMed ID: 25567231
[TBL] [Abstract][Full Text] [Related]
8. Treatment patterns and outcomes among patients with high-intermediate/high-risk diffuse large B-cell lymphoma in the USA.
Mytelka DS; Li L; Stafkey-Mailey D; Liepa AM; Hess LM; Farrelly E; Eaddy M
Hematology; 2015 Sep; 20(8):442-448. PubMed ID: 25551431
[TBL] [Abstract][Full Text] [Related]
9. Peripheral T and NK cell non-hodgkin lymphoma a challenge for diagnosis.
Vasile D; Vladareanu AM; Bumbea H
Maedica (Bucur); 2014 Mar; 9(1):104-8. PubMed ID: 25553137
[TBL] [Abstract][Full Text] [Related]
10. Statin use has negative clinical impact on non-germinal center in patients with diffuse large B cell lymphoma in rituximab era.
Song MK; Chung JS; Lee GW; Cho SH; Hong J; Shin DY; Shin HJ
Leuk Res; 2015 Feb; 39(2):211-5. PubMed ID: 25541029
[TBL] [Abstract][Full Text] [Related]
11. Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapy.
Nakajima Y; Tomita N; Itabashi M; Miyashita K; Watanabe R; Miyazaki T; Tachibana T; Takasaki H; Kawasaki R; Tanaka M; Hashimoto C; Yamazaki E; Taguchi J; Fujimaki K; Sakai R; Fujita H; Fujisawa S; Harano H; Motomura S; Ishigatsubo Y
Leuk Res; 2015 Feb; 39(2):198-203. PubMed ID: 25541027
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management.
Wilcox RA
Am J Hematol; 2015 Jan; 90(1):73-6. PubMed ID: 25535037
[TBL] [Abstract][Full Text] [Related]
13. Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989-2010.
Issa DE; van de Schans SA; Chamuleau ME; Karim-Kos HE; Wondergem M; Huijgens PC; Coebergh JW; Zweegman S; Visser O
Haematologica; 2015 Apr; 100(4):525-33. PubMed ID: 25512643
[TBL] [Abstract][Full Text] [Related]
14. Rituximab as consolidation therapy did not improve outcome in patients with diffuse large B-cell lymphoma at complete response after dose-dense chemotherapy (CHOP-14).
Avilès A; Nambo MJ; Huerta-Guzmàn J; Silva L; Neri N
Cancer Biother Radiopharm; 2015 Apr; 30(3):107-10. PubMed ID: 25871407
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine versus fentanyl as coadjuvants of balanced anaesthesia technique in renal transplant recipients.
Negi S; Sen I; Arya V; Sharma A
Middle East J Anaesthesiol; 2014 Oct; 22(6):549-57. PubMed ID: 25668998
[TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma.
Carson KR; Riedell P; Lynch R; Nabhan C; Wildes TM; Liu W; Ganti A; Roop R; Sanfilippo KM; O'Brian K; Liu J; Bartlett NL; Cashen A; Wagner-Johnston N; Fehniger TA; Colditz GA
J Geriatr Oncol; 2015 May; 6(3):211-8. PubMed ID: 25614297
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-free treatment in patients with follicular lymphoma.
Sarkozy C; Salles G; Bachy E
Expert Rev Hematol; 2015 Apr; 8(2):187-203. PubMed ID: 25585961
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of F-18 FDG PET/CT quantization parameters in diffuse large B cell lymphoma: a meta-analysis with 702 participants.
Xie M; Wu K; Liu Y; Jiang Q; Xie Y
Med Oncol; 2015 Jan; 32(1):446. PubMed ID: 25511321
[TBL] [Abstract][Full Text] [Related]
19. Rituximab and bortezomib (RB): a new effective regimen for refractory or relapsed indolent lymphomas.
Yun H; Zhang HL; Wang HQ
Med Oncol; 2015 Jan; 32(1):353. PubMed ID: 25511319
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
